Complications of Immunotherapy Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Complications of Immunotherapy. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Complications of Immunotherapy Indian Medical PG Question 1: A 45-year-old patient with a known allergy to penicillin presents with an enterococcal endocarditis. The physician needs to prescribe an antibiotic but wants to ensure it is safe for a penicillin allergy. The patient has had previous allergic reactions to penicillin including rash & swelling. Which of the following drugs can be used safely in a patient allergic to penicillin?
- A. Ceftriaxone
- B. Vancomycin (Correct Answer)
- C. Piperacillin
- D. Aztreonam
Complications of Immunotherapy Explanation: ***Vancomycin***
- **Vancomycin** is a glycopeptide antibiotic with a completely different mechanism of action and chemical structure compared to penicillins, making it **safe for patients with penicillin allergy**.
- It is the **first-line treatment for enterococcal endocarditis** in patients with penicillin allergy, providing excellent coverage against both *Enterococcus faecalis* and *E. faecium*.
- No cross-reactivity with beta-lactam antibiotics.
*Ceftriaxone*
- **Ceftriaxone** is a third-generation **cephalosporin**, a beta-lactam antibiotic with structural similarity to penicillin.
- There is **5-10% cross-reactivity risk** in patients with IgE-mediated penicillin allergy (rash, swelling, anaphylaxis), making it potentially unsafe in this patient.
- Should be avoided in patients with a history of immediate hypersensitivity reactions to penicillin.
*Piperacillin*
- **Piperacillin** is a **penicillin derivative** (ureidopenicillin) and shares the same beta-lactam core structure that triggers allergic reactions.
- **Absolutely contraindicated** in patients with known penicillin allergy—would almost certainly provoke an allergic reaction.
- Using this drug would expose the patient to significant risk of anaphylaxis.
*Aztreonam*
- **Aztreonam** is a **monobactam** with minimal cross-reactivity (<1%) with penicillins and is generally **safe for penicillin-allergic patients** from an allergy perspective.
- However, aztreonam has **primarily gram-negative coverage** and **poor activity against enterococci**, making it ineffective for treating enterococcal endocarditis.
- While safe regarding allergy concerns, it is not the appropriate choice due to **lack of efficacy** against the causative organism.
Complications of Immunotherapy Indian Medical PG Question 2: A patient comes to you with skin reactions after visiting the hair dresser. What will you do to confirm the diagnosis of contact dermatitis?
- A. S IgE
- B. Allergy Test
- C. Patch Test (Correct Answer)
- D. VDRL
Complications of Immunotherapy Explanation: ***Patch Test***
- A **patch test** is the gold standard for diagnosing **allergic contact dermatitis** by directly applying suspected allergens to the skin.
- This test identifies specific substances that cause a delayed hypersensitivity reaction, which is characteristic of contact dermatitis.
*S IgE*
- **Serum IgE** levels are primarily indicative of **Type I hypersensitivity** reactions, such as allergic rhinitis or asthma.
- Contact dermatitis is a **Type IV delayed hypersensitivity reaction**, not mediated by IgE antibodies.
*Allergy Test*
- The term "allergy test" is broad and can refer to various methods including skin prick tests, IgE blood tests, or patch tests.
- Without specifying **patch testing**, other forms of allergy tests are less appropriate for diagnosing contact dermatitis, as they target different immune mechanisms.
*VDRL*
- **VDRL (Venereal Disease Research Laboratory)** test is used to screen for **syphilis**, a sexually transmitted infection.
- It has no relevance to the diagnosis of contact dermatitis, which is an inflammatory skin condition caused by contact with an allergen or irritant.
Complications of Immunotherapy Indian Medical PG Question 3: Allograft rejection is an example of which type of hypersensitivity reaction?
- A. Type IV hypersensitivity (Correct Answer)
- B. Type I hypersensitivity
- C. Type II hypersensitivity
- D. Type III hypersensitivity
Complications of Immunotherapy Explanation: ***Delayed hypersensitivity***
- Allograft rejection primarily involves **T-cell mediated mechanisms** [1][3][5], characteristic of delayed hypersensitivity reactions [1][2].
- This type of reaction occurs days to weeks after exposure, leading to lymphocyte infiltration and tissue damage [1][4].
*Immediate hypersensitivity*
- This type is mediated by **IgE antibodies** and occurs rapidly (within minutes) upon exposure to the allergen.
- It is exemplified by **anaphylaxis**, which is not related to the T-cell-mediated rejection seen in allografts.
*Swartzmans reaction*
- This is a form of **opsonization and hypersensitivity** that results in systemic reactions due to previously sensitized antigen.
- Unlike allograft rejection, it is not specifically related to transplant rejection mechanisms.
*GVHD*
- Graft-versus-host disease (GVHD) is a complication where the **graft attacks the host's tissues** as seen in hematopoietic stem cell transplants.
- While related to immune responses, it is not the same as allograft rejection, which refers to the host's rejection of the graft.
**References:**
[1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 173-174.
[2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 216-218.
[3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 240.
[4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, p. 242.
[5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of the Immune System, pp. 240-241.
Complications of Immunotherapy Indian Medical PG Question 4: Most common skin manifestation seen after 2 days of radiation therapy is –
- A. Erythema (Correct Answer)
- B. Dermatitis
- C. Atopy
- D. Hyperpigmentation
Complications of Immunotherapy Explanation: ***Erythema***
- **Erythema** is the most common and earliest skin reaction to radiation therapy, typically appearing within hours to 2 weeks of treatment initiation
- It results from acute vasodilation and inflammation of superficial blood vessels in response to radiation-induced cellular damage
- This is the most specific and precise answer for a 2-day timeline
*Dermatitis*
- **Radiation dermatitis** is an umbrella term encompassing all skin reactions to radiation therapy, with erythema being its earliest manifestation
- While technically erythema is a form of acute radiation dermatitis, the question asks for the most specific manifestation at 2 days, which is **erythema**
- Using the general term "dermatitis" is less precise than identifying the specific initial presentation
*Atopy*
- **Atopy** refers to a genetic predisposition to developing allergic hypersensitivity reactions, such as eczema, asthma, and allergic rhinitis
- It is not a direct consequence or skin manifestation caused by radiation therapy itself
*Hyperpigmentation*
- **Hyperpigmentation** is a common late skin manifestation of radiation therapy, usually appearing weeks to months after the start of treatment or following the resolution of acute inflammation
- It is not typically seen within the first two days of radiation exposure
Complications of Immunotherapy Indian Medical PG Question 5: Skin erythema dose is:
- A. 300-400 R
- B. 400-500 R
- C. 200-300 R (Correct Answer)
- D. 100-200 R
Complications of Immunotherapy Explanation: ***200-300 R***
- The **skin erythema dose** refers to the amount of radiation exposure, expressed in Roentgens (R), that typically causes reddening of the skin.
- This range historically served as a basic measure for assessing acute radiation effects and was an early practical limit for radiation exposure in medical imaging.
*300-400 R*
- While within the broader range of doses that can cause skin effects, **300-400 R** is generally considered a higher dose than the threshold for a noticeable, transient erythema.
- Exposure at this level might lead to more pronounced or persistent skin reactions.
*400-500 R*
- Doses of **400-500 R** are significantly high and would typically cause more severe skin reactions, such as blistering or moist desquamation, rather than just transient erythema.
- This level of exposure is well beyond what is considered the skin erythema dose threshold.
*100-200 R*
- A dose of **100-200 R** is generally considered to be below the threshold for reliably inducing noticeable skin erythema in most individuals.
- While some mild, transient redness might occur in very sensitive individuals, it is not the commonly accepted range for the skin erythema dose.
Complications of Immunotherapy Indian Medical PG Question 6: Which condition is characterized by conjunctival injection, pharyngeal injection, polymorphic rash, and cervical lymphadenopathy?
- A. Kawasaki syndrome (Correct Answer)
- B. Measles
- C. Scarlet fever
- D. Mumps
Complications of Immunotherapy Explanation: ***Kawasaki syndrome***
- **Kawasaki syndrome** is characterized by a constellation of symptoms including **conjunctival injection**, **pharyngeal injection**, a **polymorphic rash**, and **cervical lymphadenopathy**, often described as the CRASH and burn criteria (Conjunctivitis, Rash, Adenopathy, Strawberry tongue, Hand/foot changes, and Fever).
- It is an acute systemic vasculitis, primarily affecting young children, and without treatment, it can lead to **coronary artery aneurysms**.
*Measles*
- Measles is characterized by a maculopapular rash that typically starts on the face and spreads downwards (cephalocaudal), along with the presence of **Koplik spots** on the buccal mucosa.
- While it presents with conjunctivitis and rash, the rash is not polymorphic in the same way as Kawasaki, and cervical lymphadenopathy is less prominent.
*Scarlet fever*
- **Scarlet fever** is caused by Group A Streptococcus and presents with pharyngitis, fever, and a characteristic **sandpaper-like erythematous rash** with circumoral pallor.
- While it has pharyngeal involvement and rash, it lacks the **conjunctival injection** and **polymorphic nature of the rash** seen in Kawasaki syndrome. The rash is typically fine and blanching.
- Cervical lymphadenopathy may be present but the overall constellation differs from Kawasaki.
*Mumps*
- Mumps is an acute viral infection primarily characterized by the swelling of the **parotid glands** (parotitis), often accompanied by fever, headache, and malaise.
- It does not typically present with conjunctival injection, a polymorphic rash, or prominent cervical lymphadenopathy as seen in Kawasaki syndrome.
Complications of Immunotherapy Indian Medical PG Question 7: Which of the following is false regarding transfusion-associated anaphylactic reactions?
- A. Different from allergy
- B. Epinephrine is the drug of choice
- C. Washed blood products prevent it
- D. Seen in IgG deficient individuals (Correct Answer)
Complications of Immunotherapy Explanation: ***Seen in IgG deficient individuals***
- Transfusion-associated **anaphylactic reactions** are most commonly seen in **IgA-deficient individuals** who develop **anti-IgA antibodies** and receive blood products containing IgA.
- Anaphylaxis occurs when these pre-formed IgA antibodies react with donor IgA, leading to mast cell degranulation and severe allergic symptoms.
*Different from allergy*
- Transfusion-associated **anaphylactic reactions** are a severe form of allergic reaction, often distinguished by their **rapid onset** and life-threatening nature [1].
- While all allergies involve an immune response to an allergen, anaphylaxis represents the most extreme systemic manifestation.
*Epinephrine is the drug of choice*
- **Epinephrine** is indeed the **first-line treatment** for acute anaphylaxis, regardless of its cause, including transfusion-associated reactions [2].
- It acts rapidly to counteract the systemic effects of histamine and other mediators by acting on α and β adrenergic receptors [3].
*Washed blood products prevent it*
- **Washing blood products** (e.g., packed red blood cells or platelets) is an effective strategy to **remove plasma proteins**, including IgA.
- This is particularly crucial for patients with a known **IgA deficiency and anti-IgA antibodies** to prevent severe anaphylactic reactions.
Complications of Immunotherapy Indian Medical PG Question 8: Which of the following are early mediators of allergic rhinitis?
- A. Leukotrienes
- B. Interleukin-4
- C. Interleukin-5
- D. Platelet-activating factor and bradykinin (Correct Answer)
Complications of Immunotherapy Explanation: ### Explanation
Allergic rhinitis is a Type I hypersensitivity reaction occurring in two distinct phases: the **Early Phase** (within minutes) and the **Late Phase** (4–8 hours later).
**Why Option D is Correct:**
The early phase is triggered when an allergen cross-links IgE antibodies on the surface of **mast cells**, leading to immediate degranulation. This releases **pre-formed mediators** and rapidly synthesized lipid mediators.
* **Histamine** is the primary mediator.
* **Platelet-activating factor (PAF), Bradykinin, and Prostaglandin D2** are also released during this immediate window, causing vasodilation, increased vascular permeability (edema), and stimulation of sensory nerves (itching/sneezing).
**Why Other Options are Incorrect:**
* **A. Leukotrienes:** While Cysteinyl Leukotrienes (CysLTs) are produced during the early phase, they are most characteristic of the transition to and maintenance of the **Late Phase** response, contributing significantly to prolonged nasal congestion.
* **B & C. Interleukin-4 and Interleukin-5:** These are **cytokines** produced by Th2 lymphocytes. They are involved in the **Late Phase** response. IL-4 promotes IgE isotype switching, while IL-5 is the primary factor for **eosinophil** recruitment and activation.
**NEET-PG High-Yield Pearls:**
1. **Early Phase (Minutes):** Mediated by Mast cells. Key symptoms: Sneezing, itching, rhinorrhea. Key mediator: Histamine.
2. **Late Phase (Hours):** Mediated by Eosinophils, Basophils, and Th2 cells. Key symptom: Nasal congestion.
3. **Gold Standard Diagnosis:** Skin Prick Test (detects specific IgE).
4. **Pharmacology Link:** Antihistamines work best on early-phase symptoms (itch/sneeze), while Intranasal Steroids are the most effective treatment for late-phase symptoms (congestion) because they inhibit cytokine release.
Complications of Immunotherapy Indian Medical PG Question 9: Which of the following preformed toxins is involved in the mechanism of allergic rhinitis?
- A. Histamine (Correct Answer)
- B. Leukotriene
- C. TXA2
- D. PGD2
Complications of Immunotherapy Explanation: Allergic rhinitis is a **Type I Hypersensitivity reaction** mediated by IgE antibodies. When an allergen cross-links IgE on the surface of mast cells, it triggers **degranulation**, releasing two types of chemical mediators: **Preformed mediators** (stored in granules) and **Newly synthesized mediators** (produced after activation).
### Why Histamine is Correct
**Histamine** is the primary **preformed mediator** stored in the granules of mast cells and basophils. Upon degranulation, it is released immediately (within minutes), causing the "Early Phase" symptoms of allergic rhinitis: vasodilation, increased capillary permeability (edema/nasal block), and stimulation of sensory nerves (itching/sneezing).
### Why Other Options are Incorrect
* **Leukotrienes (B):** These are **newly synthesized** mediators derived from arachidonic acid via the lipoxygenase pathway. While potent (causing mucus secretion and congestion), they are produced *after* mast cell activation and are not pre-stored.
* **TXA2 (Thromboxane A2) (C):** This is a product of the cyclooxygenase pathway primarily involved in platelet aggregation and vasoconstriction; it plays a minimal role in the pathophysiology of allergic rhinitis.
* **PGD2 (Prostaglandin D2) (D):** Like leukotrienes, PGD2 is a **newly synthesized** mediator produced via the cyclooxygenase pathway. It contributes to late-phase inflammation but is not preformed.
### NEET-PG High-Yield Pearls
* **Early Phase Response:** Mediated by **Histamine** (Preformed). Occurs within minutes.
* **Late Phase Response:** Mediated by **Leukotrienes, PGD2, and Cytokines**. Occurs 4–8 hours later; characterized by eosinophil infiltration.
* **Drug of Choice:** Intranasal corticosteroids are the most effective maintenance therapy for allergic rhinitis.
* **Gold Standard Test:** Skin Prick Test (SPT) is used to identify specific allergens.
Complications of Immunotherapy Indian Medical PG Question 10: A 29-year-old non-smoker man presents with sneezing, post-nasal drip, eye-watering, and an itch of his posterior pharynx. These symptoms tend to be worse in the spring and summer and have been bothering him since mid-April. His past medical history is remarkable only for mild asthma induced by being outdoors. He takes no regular medications but does take diphenhydramine on occasion. What is the most appropriate diagnostic test at this time?
- A. Blood radioallergosorbent test
- B. None, the diagnosis is based solely on the history and physical examination (Correct Answer)
- C. Intradermal testing
- D. Serum protein electrophoresis
Complications of Immunotherapy Explanation: **Explanation:**
The patient presents with classic symptoms of **Allergic Rhinitis (AR)**: paroxysmal sneezing, post-nasal drip, ocular symptoms (watering), and palatal itching. The seasonal pattern (spring/summer) and comorbid mild asthma strongly suggest **Seasonal Allergic Rhinitis**.
**1. Why Option B is Correct:**
In clinical practice, the diagnosis of Allergic Rhinitis is primarily **clinical**, based on a characteristic history and physical examination (e.g., pale/bluish nasal mucosa, turbinate hypertrophy). Diagnostic testing is **not mandatory** for initial management. Testing (like Skin Prick Tests) is typically reserved for patients who do not respond to empirical therapy (intranasal corticosteroids/antihistamines) or those being considered for allergen-specific immunotherapy.
**2. Why Other Options are Incorrect:**
* **Option A (RAST):** This measures allergen-specific IgE in the blood. While useful if skin testing is contraindicated (e.g., severe eczema or antihistamine use), it is more expensive and less sensitive than skin testing. It is not the first-line diagnostic step.
* **Option C (Intradermal testing):** This is more sensitive but less specific than the Skin Prick Test (SPT). It carries a higher risk of systemic anaphylaxis and is generally used only if SPT is negative despite a strong clinical suspicion.
* **Option D (Serum protein electrophoresis):** This is used to diagnose plasma cell dyscrasias (like Multiple Myeloma) and has no role in the diagnosis of allergy.
**Clinical Pearls for NEET-PG:**
* **First-line treatment for AR:** Intranasal Corticosteroids (e.g., Fluticasone).
* **Allergic Shiners:** Dark circles under eyes due to venous congestion.
* **Allergic Salute:** Upward rubbing of the nose leading to a **transverse nasal crease**.
* **Gold Standard for identifying allergens:** Skin Prick Test (SPT).
* **Definitive/Disease-modifying treatment:** Immunotherapy (SIT/SLIT).
More Complications of Immunotherapy Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
